Market Overview:
The global Abthrax market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidences of anthrax, increasing awareness about the disease and its prevention, and growing demand for Abthrax for prophylaxis and treatment of inhalational anthrax. However, lack of awareness about inhalational anthrax among people in developing countries is a major challenge faced by the global Abthrax market. Based on type, the global Abthrax market can be segmented into treat inhalational anthrax and prevent inhalational anthax. The treat inhalational anthax segment is expected to account for a larger share of the global Abthrx marke than th prevent inhaltional anhtx segmnt durin th frst dy f th prdyctd perid.
Product Definition:
Abthrax is an anthrax vaccine used to prevent the disease in people who may be exposed to it.
Treat Inhalational Anthrax:
Treat inhalational anthrax, also known as Abthrix, is a drug used to treat patients infected with Bacillus anthracis. It is the only medication approved by the U.S. FDA for treatment of inhalational anthrax and it works by killing bacteria in the airways leading to respiratory failure. The drug was developed at Merck & Co., Inc.
Prevent Inhalational Anthrax:
Prevent inhalational anthrax (PIA) is a vaccine developed to prevent Anthrax disease. It is given by injection into the muscle of the upper arm, above the elbow. The vaccine consists of a weakened form of Bacillus anthracis spores that are bound together with protein and stabilizer.
Anthrax bacteria are gram-positive bacteria that live in soil and mud for months without causing any harm to animals or plants around them.
Application Insights:
Drug store accounted for the largest share of revenue in 2017 owing to increasing incidences of abthrax-related infections. The drugs store application segment is projected to grow at a CAGR of XX% over the forecast period, in terms of volume. Increasing number abbortsions and number dying from abthrax are driving the demand for Abaxis Ltd¢â‚¬â„¢s Anthrax Vaccine Adsorbed (AVA) globally, which is expected to fuel market growth during this period.
The hospital application segment was valued at USD 544 million in 2017 owing to rising awareness about preventable diseases and government initiatives that aim towards their eradication such as WHO Global Immunization Vision and Strategy 2016-2020 which aims towards measles elimination by 2020 and polio eradication by 2030 thus boosting product demand globally during this period.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, advanced healthcare infrastructure and high government spending on anthrax vaccines are some of the factors responsible for its dominance. In addition, favorable reimbursement policies for AbbVax purchase are also expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to increasing focus of governments on controlling diseases such as anthrax and other highly infectious diseases that pose a threat to public health & safety due to lack of awareness about these infections among people coupled with under-implementation or absence of regulatory reforms in countries like India & China which has resulted into low penetration rates for these drugs leading toward higher revenue generation opportunities in this region over the next eight years. ‘’The Anthrax Vaccine Enterprise’ (AVX) is an initiative by Merck & Co.
Growth Factors:
- Increasing incidence of anthrax infections: The incidence of anthrax is increasing due to various reasons such as bioterrorism, animal exposure, and international travel. This is expected to drive the demand for Abthrax in the coming years.
- Availability of funding for R&D: The availability of funding for R&D in the field of Abthrax is driving the growth of this market. Various companies are investing in this area to develop new and innovative therapies for anthrax infections.
- Emergence of resistant strains: The emergence of resistant strains is a major challenge faced by the Abthrax market. However, with continuous research and development activities, newer therapies are being developed that can overcome these resistance issues.
Scope Of The Report
Report Attributes
Report Details
Report Title
Abthrax Market Research Report
By Type
Treat Inhalational Anthrax, Prevent Inhalational Anthrax
By Application
Hospital, Drugs Store, Other
By Companies
GlaxoSmithKline, GlaxoSmithKline
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
249
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Abthrax Market Report Segments:
The global Abthrax market is segmented on the basis of:
Types
Treat Inhalational Anthrax, Prevent Inhalational Anthrax
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drugs Store, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GlaxoSmithKline
- GlaxoSmithKline
Highlights of The Abthrax Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Treat Inhalational Anthrax
- Prevent Inhalational Anthrax
- By Application:
- Hospital
- Drugs Store
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Abthrax Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Abthrax is a rare and serious bacterial infection caused by the bacterium Abthrax aegypti. It can cause severe respiratory illness in people of all ages, and can be fatal. Symptoms include fever, coughing, shortness of breath, chest pain, and difficulty breathing. Treatment involves antibiotics to fight the bacteria.
Some of the major players in the abthrax market are GlaxoSmithKline, GlaxoSmithKline.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Abthrax Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Abthrax Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Abthrax Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Abthrax Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Abthrax Market Size & Forecast, 2018-2028
4.5.1 Abthrax Market Size and Y-o-Y Growth
4.5.2 Abthrax Market Absolute $ Opportunity
Chapter 5 Global Abthrax Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Abthrax Market Size Forecast by Type
5.2.1 Treat Inhalational Anthrax
5.2.2 Prevent Inhalational Anthrax
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Abthrax Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Abthrax Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drugs Store
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Abthrax Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Abthrax Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Abthrax Analysis and Forecast
9.1 Introduction
9.2 North America Abthrax Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Abthrax Market Size Forecast by Type
9.6.1 Treat Inhalational Anthrax
9.6.2 Prevent Inhalational Anthrax
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Abthrax Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drugs Store
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Abthrax Analysis and Forecast
10.1 Introduction
10.2 Europe Abthrax Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Abthrax Market Size Forecast by Type
10.6.1 Treat Inhalational Anthrax
10.6.2 Prevent Inhalational Anthrax
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Abthrax Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drugs Store
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Abthrax Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Abthrax Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Abthrax Market Size Forecast by Type
11.6.1 Treat Inhalational Anthrax
11.6.2 Prevent Inhalational Anthrax
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Abthrax Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drugs Store
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Abthrax Analysis and Forecast
12.1 Introduction
12.2 Latin America Abthrax Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Abthrax Market Size Forecast by Type
12.6.1 Treat Inhalational Anthrax
12.6.2 Prevent Inhalational Anthrax
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Abthrax Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drugs Store
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Abthrax Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Abthrax Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Abthrax Market Size Forecast by Type
13.6.1 Treat Inhalational Anthrax
13.6.2 Prevent Inhalational Anthrax
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Abthrax Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drugs Store
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Abthrax Market: Competitive Dashboard
14.2 Global Abthrax Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GlaxoSmithKline
14.3.2 GlaxoSmithKline
